Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Masuda

Showing results (171-180 of 249) with videos related to

Pageof 25
Sort By:
Japanese Journal of Clinical Oncology|October 29, 2025
Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trialShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Journal of Urology|August 22, 2017
Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational StudyYasuhiro Kaiho, Hitoshi Masuda, Mineo Takei, et al.
European Urology Open Science|February 16, 2026
Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysisShugo Yajima, Wei Chen, Kohei Hirose, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 18, 2026
Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup ResultsKenji Tanabe, Soichiro Yoshida, Wei Chen, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 4, 2013
[Case of inflammatory lesion in urinary bladder showing high signal intensity on diffusion-weighted MRI: correlation with histopathological finding]Shingo Moriyama, Soichiro Yoshida, Hideki Takeshita, et al.
The Journal of Urology|February 10, 2004
Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancerFumitaka Koga, Yukio Kageyama, Satoru Kawakami, et al.
BJU International|February 29, 2012
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancerToshiki Kijima, Yasuhisa Fujii, Minato Yokoyama, et al.
BMC Urology|July 23, 2013
Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year studyManabu Tatokoro, Kazunori Kihara, Hitoshi Masuda, et al.
Clinical Genitourinary Cancer|October 31, 2013
Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancerFumitaka Koga, Shuichiro Kobayashi, Yasuhisa Fujii, et al.
Targeted Oncology|January 23, 2026
Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysisHiroshi Fukushima, Shugo Yajima, Wei Chen, et al.
Pageof 25

Showing results (171-180 of 249) with videos related to

Sort By:
Pageof 25
Japanese Journal of Clinical Oncology|October 29, 2025
Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trialShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Journal of Urology|August 22, 2017
Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational StudyYasuhiro Kaiho, Hitoshi Masuda, Mineo Takei, et al.
European Urology Open Science|February 16, 2026
Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysisShugo Yajima, Wei Chen, Kohei Hirose, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 18, 2026
Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup ResultsKenji Tanabe, Soichiro Yoshida, Wei Chen, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 4, 2013
[Case of inflammatory lesion in urinary bladder showing high signal intensity on diffusion-weighted MRI: correlation with histopathological finding]Shingo Moriyama, Soichiro Yoshida, Hideki Takeshita, et al.
The Journal of Urology|February 10, 2004
Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancerFumitaka Koga, Yukio Kageyama, Satoru Kawakami, et al.
BJU International|February 29, 2012
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancerToshiki Kijima, Yasuhisa Fujii, Minato Yokoyama, et al.
BMC Urology|July 23, 2013
Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year studyManabu Tatokoro, Kazunori Kihara, Hitoshi Masuda, et al.
Clinical Genitourinary Cancer|October 31, 2013
Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancerFumitaka Koga, Shuichiro Kobayashi, Yasuhisa Fujii, et al.
Targeted Oncology|January 23, 2026
Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysisHiroshi Fukushima, Shugo Yajima, Wei Chen, et al.
Pageof 25